Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (151-160 of 289) with videos related to

Pageof 29
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 5, 2015
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studiesHak Choy, David E Gerber, Jeffrey D Bradley, et al.
Journal of the American College of Radiology : JACR|February 10, 2022
Implementation and Uptake of Rural Lung Cancer ScreeningTri Le, Stacie Miller, Emily Berry, et al.
Clinical Lung Cancer|June 7, 2016
Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung CancerDavid E Gerber, David R Spigel, David Giorgadze, et al.
JAMA Network Open|June 24, 2026
Patient Perspectives on Electronic Communication of Cancer DiagnosesSheena Bhalla, Meera J Patel, Lauren Abruzzo, et al.
Cancers|November 27, 2024
Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing DisparitiesKalyani Narra, Madison Hull, Kari J Teigen, et al.
Cell Reports. Medicine|July 18, 2020
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation BurdenDavid Hsiehchen, Antony Hsieh, Robert M Samstein, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysisLin Yang, Shidan Wang, David E Gerber, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Contemporary Clinical Trials|July 10, 2017
Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trialDavid E Gerber, Heidi A Hamann, Noel O Santini, et al.
Cancer Medicine|August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trialCaitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Pageof 29

Showing results (151-160 of 289) with videos related to

Sort By:
Pageof 29
Lung Cancer (Amsterdam, Netherlands)|February 5, 2015
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studiesHak Choy, David E Gerber, Jeffrey D Bradley, et al.
Journal of the American College of Radiology : JACR|February 10, 2022
Implementation and Uptake of Rural Lung Cancer ScreeningTri Le, Stacie Miller, Emily Berry, et al.
Clinical Lung Cancer|June 7, 2016
Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung CancerDavid E Gerber, David R Spigel, David Giorgadze, et al.
JAMA Network Open|June 24, 2026
Patient Perspectives on Electronic Communication of Cancer DiagnosesSheena Bhalla, Meera J Patel, Lauren Abruzzo, et al.
Cancers|November 27, 2024
Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing DisparitiesKalyani Narra, Madison Hull, Kari J Teigen, et al.
Cell Reports. Medicine|July 18, 2020
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation BurdenDavid Hsiehchen, Antony Hsieh, Robert M Samstein, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysisLin Yang, Shidan Wang, David E Gerber, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Contemporary Clinical Trials|July 10, 2017
Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trialDavid E Gerber, Heidi A Hamann, Noel O Santini, et al.
Cancer Medicine|August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trialCaitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Pageof 29